Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Bausch Health Companies Inc. (BHC)

$4.43 -0.45% NYSE: BHC · 15-min delayed
  • QUEBEC,
  • Public · NYSE: BHC
  • 20,300 employees
$2.0BMarket cap
$10.3BRevenue · FY2025
$157.0MNet income
20,300Employees
BHCNYSE
1994IPO

About Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$10.3B
Net income
$157.0M
Total assets
$26.4B
Market cap
$2.0B
Operating margin
17.7%
Net margin
1.2%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$10.3B
Operating expenses
$8.5B
Operating income
$1.8B
Income tax
$247.0M
Net income
$120.0M
EPS (basic)
$0.42
EPS (diluted)
$0.42

Balance sheet

Total assets
$26.4B
Current assets
$6.2B
Total liabilities
$26.0B
Current liabilities
$4.2B
Shareholders’ equity
$377.0M

Cash flow

Operating cash flow
$1.4B
Investing cash flow
-$595.0M
Financing cash flow
-$742.0M
Net cash flow
$124.0M

Statements via Polygon.io (SEC filings)

NYSE: BHC
$4.43 -0.45%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$4.43 $8.34

52-week range

Market cap
$2.0B
P/E ratio
10.5
EPS (diluted)
$0.42
Shares outstanding
452.7M
Open
Day range
Prev close
Volume
IPO date
Mar 31, 1994

Bausch Health Companies Inc. (BHC) Stock Price

  • Profitable — net income of $157.0M in FY2025.
  • Revenue grew 22% from FY2021 to FY2025.
  • Trading 47% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 10.5.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Bausch Health Companies Inc..

Write a review
Newsroom

News about Bausch Health Companies Inc.

News & sentiment via Polygon.io

FAQ

Bausch Health Companies Inc.: frequently asked questions

Is Bausch Health Companies Inc. an American company?

Bausch Health Companies Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Bausch Health Companies Inc. publicly traded?

Yes — Bausch Health Companies Inc. is a publicly traded company. Its stock trades under the ticker symbol BHC on the NYSE.

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →